Renal Fibrosis Is Alleviated through Targeted Inhibition of IL-11–Induced Renal Tubular Epithelial-to-Mesenchymal Transition
The American Journal of Pathology · 2023-12 · 193 (12) · 1936-1952
DOI: 10.1016/j.ajpath.2023.07.005 ↗Kurz gefasst
Fachartikel in der Zeitschrift The American Journal of Pathology, 2023-12. Verfasst von Yaqin Li und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Practice, Zhujiang Hospital, Southern Medical University, Guangzhou, China. Hauptthemen laut MEDLINE: Epithelial-Mesenchymal Transition, Kidney Diseases, Ureteral Obstruction. Die Arbeit wurde bisher 34-mal zitiert (Crossref) und nennt 37 Literaturangaben. Gefördert von: Guangzhou Municipal Science and Technology Project, National Natural Science Foundation of China, Natural Science Foundation of Guangdong Province.
Abstract (Originalsprache)
Renal fibrosis is a pathologic process that leads to irreversible renal failure without effective treatment. Epithelial-to-mesenchymal transition (EMT) plays a key role in this process. The current study found that aberrant expression of IL-11 is critically involved in tubular EMT. IL-11 and its receptor subunit alpha-1 (IL-11Rα1) were significantly induced in renal tubular epithelial cells (RTECs) in unilateral ureteral obstruction (UUO) kidneys, co-localized with transforming growth factor-β1. IL-11 knockdown ameliorated UUO-induced renal fibrosis in vivo and transforming growth factor-β1-induced EMT in vitro. IL-11 intervention directly induced the transdifferentiation of RTECs to the mesenchymal phenotype and increased the synthesis of profibrotic mediators. The EMT response induced by IL-11 was dependent on the sequential activation of STAT3 and extracellular signal-regulated kinase 1/2 signaling pathways and the up-regulation of metadherin in RTECs. Micheliolide (MCL) competitively inhibited the binding of IL-11 with IL-11Rα1, suppressing the activation of STAT3 and extracellular signal-regulated kinase 1/2-metadherin pathways, ultimately inhibiting renal tubular EMT and interstitial fibrosis induced by IL-11. In addition, treatment with dimethylaminomicheliolide, a pro-drug of MCL for in vivo use, significantly ameliorated renal fibrosis exacerbated by IL-11 in the UUO model. These findings suggest that IL-11 is a promising target in renal fibrosis and that MCL/dimethylaminomicheliolide exerts its antifibrotic effect by suppressing IL-11/IL-11Rα1 interaction and blocking its downstream effects.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of General Practice, Zhujiang Hospital, Southern Medical University, Guangzhou, China.
- Department of Nephrology, Zhujiang Hospital, Southern Medical University, Guangzhou, China.
- Department of Gerontology, Zhujiang Hospital, Southern Medical University, Guangzhou, China.
- Department of Emergency, Zhujiang Hospital, Southern Medical University, Guangzhou, China.
- Department of Nephrology, Zhujiang Hospital, Southern Medical University, Guangzhou, China. Electronic address: longhb1966@163.com.
- Department of Emergency, Zhujiang Hospital, Southern Medical University, Guangzhou, China. Electronic address: xzz1008@163.com.
Förderung
- Guangzhou Municipal Science and Technology Project
- National Natural Science Foundation of China
- Natural Science Foundation of Guangdong Province
Zitieren
APA
Li, Y., Luo, C., Zeng, Y., Zheng, Z., Tao, D., Liu, Q., Hong, Y., Wang, S., Long, H., & Xu, Z. (2023). Renal Fibrosis Is Alleviated through Targeted Inhibition of IL-11–Induced Renal Tubular Epithelial-to-Mesenchymal Transition. The American Journal of Pathology, 193(12), 1936-1952. https://doi.org/10.1016/j.ajpath.2023.07.005
Vancouver
Li Y, Luo C, Zeng Y, Zheng Z, Tao D, Liu Q, et al. Renal Fibrosis Is Alleviated through Targeted Inhibition of IL-11–Induced Renal Tubular Epithelial-to-Mesenchymal Transition. The American Journal of Pathology. 2023;193(12):1936-1952. doi:10.1016/j.ajpath.2023.07.005
BibTeX
@article{Li2023,
author = {Li, Yaqin and Luo, Congwei and Zeng, Yiqun and Zheng, Zerong and Tao, Danping and Liu, Qiao and Hong, Yiyu and Wang, Shuo and Long, Haibo and Xu, Zhaozhong},
title = {Renal Fibrosis Is Alleviated through Targeted Inhibition of IL-11–Induced Renal Tubular Epithelial-to-Mesenchymal Transition},
journal = {The American Journal of Pathology},
year = {2023},
volume = {193},
number = {12},
pages = {1936--1952},
doi = {10.1016/j.ajpath.2023.07.005}
}
EUVIMED